Week of December 13, 2022 | Vol. 11, Issue 48

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider



Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Jazz

Pharma Services | Sell-Side

Acquisition opportunity of US compounding pharmacy and pharmacy services provider

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of US OTC CDMO

Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Tjoapack strengthens its Injectables offering with addition of pre-filled syringes assembly and packaging services

Tjoapack - November 30, 2022

Experic Closes $14 Million Series B Financing

Business Wire - November 30, 2022

August Bioservices Closes $65M Series B

Business Wire - December 1, 2022

Purolite Opens New Pharmaceutical Manufacturing Facility in King of Prussia

Contract Pharma - December 5, 2022

Recipharm announces extension of commercial manufacturing to support RedHill Biopharma's Talicia® to 2026

Recipharm - December 5, 2022

GSK, Sanofi, Takeda, Singapore Researchers Partner to Boost Biologics Innovation

Contract Pharma - December 6, 2022

AbbVie, HotSpot Therapeutics Enter Strategic Immunology Alliance

Contract Pharma - December 6, 2022

Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities at its European Center of Excellence for Cell Therapies in Gosselies, Belgium

Catalent - December 8, 2022

Vertex, Entrada Establish EEV Therapeutics Alliance for Myotonic Dystrophy

Contract Pharma - December 8, 2022

TANNER NEWS

WHITEPAPER: Bridging the Gap from Pharma to Patient

How can pharma companies maintain supply continuity of their products amid fluctuating demands and unpredictable global challenges? Download our newest whitepaper examining some of the reasons behind the unavailability of medical products and how demand can be met efficiently and compliantly even in times of uncertainty.

Medicine Should Have No Borders

Most countries have a pathway for patients to get access to a medicine that isn’t available in their country or is still in clinical development. Early Access Programs are a pathway by which pharma and biopharmaceutical companies provide innovative drugs to patients with serious conditions—allowing manufacturers the opportunity to simultaneously build relationships with KOLs & physicians, collect RWE & support patients in need. Learn more.